What is the optimum dose of type a botulinum toxin for treating neurogenic bladder overactivity?
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Sharon Wood.
Explore the source record for details and available documents.
To ascertain the mechanisms underlying low caloric intake and low body weight in the Lou/C rat, the circulating hormone levels and gene expression of hypothalamic peptides and receptors important in energy balance and the induction of suppressor of cytokine signalling 3 (SOCS3) gene expression in response to leptin challenge were compared with Wistar rats. Plasma leptin levels were lower in the Lou/C rat, as were levels of rat corticosterone, TSH and T4 but not T3. Ghrelin levels were higher in the Lou/C rat. Total leptin receptor (Ob-R) and the long form of the leptin receptor (Ob-Rb) gene expression were lower in the arcuate (ARC) and ventromedial nuclei (VMN) in Lou/C rat. Ghrelin receptor expression in the ARC and VMN was lower in Lou/C than in Wistar rats. However, agouti gene-related peptide (AgRP) and neuropeptide Y (NPY) gene expression were higher in the Lou/C rat. There was no difference in the level of cocaine- and amphetamine-regulated transcript gene expression in the ARC, but both were higher in the paraventricular nuclei of the Lou/C breed. There was no difference in Ob-R gene expression in, or [(125)I]leptin binding to, the choroid plexus. SOCS3 mRNA induction in response to leptin was lower in the Lou/C rat. This study reveals that the comparatively low plasma leptin, TSH and T4 levels, and high ghrelin levels together with high levels of AgRP and NPY gene expression seen in the Lou/C rat are indicative of a strong drive to eat and decreased energy expenditure, which are in direct opposition to the comparatively low body weight and adiposity of this rat strain.
This Part has explored some of the epidemiological factors that affect pain. The differences between acute and chronic pain have been discussed in terms of disease process, anatomy and physiology and associated signs and symptoms.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Trigeminal neuralgia is one of the most common causes of facial pain. It can be excruciating and can severely incapacitate patients and negatively affect their quality of life. First-line treatment is anticonvulsant drugs but other pharmacological options are available. If drug therapy is ineffective, a range of surgical options exist.
Pain is one of the most complex human experiences. Nurses have a moral, ethical, humanitarian and professional responsibility to provide an adequate standard of pain assessment and documentation. In order to obtain an accurate pain assessment from patients, they need to feel that their expression of pain will be listened to, accepted and acted on. It is therefore vital that nurses are educated in the process of pain assessment.
Explore the source record for details and available documents.
In the past 30 years there has been a rise in anecdotal evidence from patients on the effectiveness of cannabis in pain relief. This has led to an interest in the potential medical use of cannabis and its derivatives (Ware et al, 2003). In the UK this debate has led to expert bodies reviewing the evidence for and against its use in pain management. This article explores this evidence.
Explore the source record for details and available documents.